NO Headache SA
NO Headache reported total assets of 261,728 € at the end of the 2025 financial year (annual accounts filed with the NBB on 11 Jul 2026).
The score of NO Headache shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +3 % Total assets +2 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
NO Headache's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 11 Jul 2026
- Year ended 31 Dec 2024filed on 26 Jun 2025
- Year ended 30 Jun 2023filed on 29 Jan 2024
- Year ended 30 Jun 2022filed on 31 Jan 2023
- Year ended 30 Jun 2021filed on 15 Jan 2022
NO Headache's financial analysis
- Solvency73.3%sector median: 61.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of NO Headache
NO Headache's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0430.126.506
- VAT number
- BE0430126506
- Peppol
- Registered · 0208:0430126506 · as of 11 Nov 2026
- Legal form
- SA
- Incorporated
- 15 Dec 1986
- Registered office
- 1180 Uccle
- Latest accounts
- 2025 · filed on 11 Jul 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
NO Headache (SA) has been based in Uccle since 1986, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net profit of 2,610 € and equity of 191,893 €; its revenue is not published. Its solvency stands at 73.3%, above the median of its sector (61.2%).
Companies similar to NO Headache
Companies in the same business, of comparable size and area, outside its group.
- APR Pharma Manufacture of basic pharmaceutical products Courcelles · balance sheet 244,955 €
- Clinical Research Vanackere Manufacture of basic pharmaceutical products Tielt-Winge · balance sheet 263,927 €
- Novozymatic Manufacture of basic pharmaceutical products Kapellen · balance sheet 148,440 €
- GRNR Invest Manufacture of basic pharmaceutical products Zemst · balance sheet €2.26m
- huMAN Manufacture of basic pharmaceutical products Gerpinnes · balance sheet 186,227 €
- Medipharm Worldwide Group Manufacture of basic pharmaceutical products Tienen · balance sheet 331,081 €
- QP Pro Services Manufacture of basic pharmaceutical products Gembloux · balance sheet 304,804 €
- Yaro Preclinical Consulting Manufacture of basic pharmaceutical products Turnhout · balance sheet 158,481 €
Frequently asked questions about NO Headache
What is the revenue of NO Headache?
NO Headache files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of NO Headache?
In Belgium, the VAT number is the company number prefixed with BE: BE0430126506 for NO Headache, if the company is VAT-registered. Its company number (CBE) is 0430.126.506.
Where is the registered office of NO Headache?
According to the CBE register, the registered office of NO Headache is in 1180 Uccle.
What is the equity of NO Headache?
At the close of the 2025 financial year, the equity of NO Headache amounts to 191,893 €, a solvency of 73.3% of total assets.
Who manages NO Headache?
The register lists 2 active mandates at NO Headache. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of NO Headache
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →